This article is more than 5 years old. Information may no longer be current.
VIDEO: Peter Hunt, MD, reviews comorbidities, inflammation in HIV
Click Here to Manage Email Alerts
SEATTLE — Peter Hunt, MD, associate professor of medicine, division of experimental medicine at the University of California, San Francisco, and member of the CROI 2017 program committee, discusses a session that focused on inflammation and age-related complications in patients with HIV. The session included data on an IL-1 beta inhibitor against atherosclerotic inflammation; the relationship between protease inhibitors and cardiovascular disease; and the impact of smoking cessation on cancer incidence in HIV–infected patients.
“The risk of severe clinical events like cancers, heart attacks and even death attributable to smoking in HIV is actually even higher than it is in the general population, so quitting smoking probably has an even greater benefit for people living with HIV than it does in people without HIV infection,” Hunt says.
Disclosure: Hunt reports being a consultant for Gilead Sciences, Merck and ViiV Healthcare